Chipscreen Biosciences, Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Shenzhen China (2001)

Organization Overview

First Clinical Trial
2013
NCT01836679
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chipscreen Biosciences, Ltd.